Latest filing published 24 Mar 2026 for Neuronetics, Inc., €54k. Read the official filing
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Keith J. Sullivan across 5 companies, led by Zeltiq Aesthetics Inc, Neuronetics, Inc. and Sientra, Inc. In total, 76 filings cover trades dated from 4 January 2016 to 19 March 2026.
On the open market, the record shows 3 purchases worth €279k and 31 sales worth €3.6M. Taken together, the sales exceed the purchases by €3.3M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 34 share grants and 8 option exercises. Since January 2026: no purchases and 4 sales on the market.
Half of the purchases are above €89k and half below.
On 24 March 2026 came the latest disclosure, an open-market sale for €54k in Neuronetics, Inc. The latest purchase dates back some time: it was published 1,769 days ago, on 17 December 2021. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 76 declarations